Page last updated: 2024-09-03

astragaloside a and rifampin

astragaloside a has been researched along with rifampin in 1 studies

Compound Research Comparison

Studies
(astragaloside a)
Trials
(astragaloside a)
Recent Studies (post-2010)
(astragaloside a)
Studies
(rifampin)
Trials
(rifampin)
Recent Studies (post-2010) (rifampin)
675557320,4681,4996,552

Protein Interaction Comparison

ProteinTaxonomyastragaloside a (IC50)rifampin (IC50)
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.949
Caspase-1Homo sapiens (human)8.319
Alpha-synucleinHomo sapiens (human)7.1
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv0.03
DNA-directed RNA polymerase subunit betaMycobacterium tuberculosis H37Rv0.01
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Britza, SM; Byard, RW; Musgrave, IF1

Other Studies

1 other study(ies) available for astragaloside a and rifampin

ArticleYear
Implications for herbal polypharmacy: coumarin-induced hepatotoxicity increased through common herbal phytochemicals astragaloside IV and atractylenolide I.
    Toxicology mechanisms and methods, 2022, Volume: 32, Issue:8

    Topics: Chemical and Drug Induced Liver Injury; Coumarins; Cytochrome P-450 Enzyme System; Herb-Drug Interactions; Humans; Lactones; Phytochemicals; Polypharmacy; Rifampin; Saponins; Sesquiterpenes; Triterpenes

2022